Clinical Trial Update: M3541 in Combination With Radiotherapy in Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 trial of M3541 in combination with radiotherapy in solid tumors was terminated; results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• M3541

Snippet

Sponsor: EMD Serono Research & Development Institute, Inc. | Conditions: Solid Tumors | Phase 1 | Status: TERMINATED | Results posted: 2023-11-22